Investing Profile

Todd Foley

VCInvestor
Managing Director at MPM BioImpact
mpmcapital.com/team/Boston, Massachusetts
Photo of Todd Foley, Managing Director at MPM Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
MPM Capital Managing Director
$1M - $150.0M
$25.0M
16
$100M
CompanyStageDateRound SizeTotal Raised
āshibio
Series AJun 2024$40M
$40M
Firefly Bio
Series AFeb 2024$94M
$94M
Co-investors: Jerel Davis (Versant Ventures)
Crossbow Therapeutics
Series AJul 2023$80M
$80M
Aktis Oncology
Series AAug 2022$84M
Series AMar 2021$72M
$330M
Co-investors: Jason Ruth (5am Ventures), Andrew Levin (RA Capital)
Iconic Therapeutics
Series UnknownJun 2018$4M
Series CAug 2016$10M
Series CJan 2016$40M
Series BApr 2014$20M
$74M
Co-investors: William Greene (MPM Capital)
Semma Therapeutics
Series AMar 2015$44M
$44M
Co-investors: Stephen Oesterle
Clinical Ink
Series UnknownMar 2015$20M
$20M
Chiasma
Series EFeb 2015$70M
Series DJul 2012$39M
Series CNov 2006$44M
$160M
Co-investors: Scott Minick (ARCH Venture Partners), Bard Geesaman (MPM Capital), Ansbert Gadicke (MPM Capital), Vincent Miles (Abingworth)